Stocks
Takeda Pharmaceutical Company LimitedTAK
NYSEHealthcareBiotechnology$17.77+0.00%
A global biopharmaceutical leader focused on developing innovative medicines in oncology, rare diseases, neuroscience, and gastroenterology. Investors monitor Takeda for its strong pipeline, recent acquisitions like Shire, and its position as Japan's largest pharmaceutical company.
Market Cap: $56.1B52W Range: $12.99 – $18.82
Congressional Interest in Takeda Pharmaceutical Company Limited (TAK)
2 members of Congress have disclosed 16 trades in Takeda Pharmaceutical Company Limited (TAK), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
16
Unique Politicians
2
Buys
11
Sells
5
Who in Congress Is Trading TAK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2011-03-04 | MICHAEL T. MCCAUL | buy | — |
| 2010-09-03 | MICHAEL T. MCCAUL | buy | $1K – $15K |